| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/21/2003 | CN1108798C Compound preparation for curing and preventing thrombosis and apoplexy and its preparing method |
| 05/21/2003 | CN1108797C Quinazolinone pharmaceuticals and use thereof |
| 05/21/2003 | CN1108796C Use of anticancer material and production method of said anti-cancer material |
| 05/21/2003 | CN1108795C Treatment of uterine contractility disorders with a nitric oxide synthase substrate and/or doner, or a nitric oxide inhibitor |
| 05/21/2003 | CN1108794C Treatment medicine or precautionary medicine for hyperlipemia |
| 05/21/2003 | CN1108793C Use of isovaleramide as a mild anxiolytic and milk sedative agent |
| 05/21/2003 | CN1108792C External-use medicine composition for treating angioma and preparation method thereof |
| 05/21/2003 | CN1108791C Galenic formula with extended release of milnacipran |
| 05/21/2003 | CN1108790C Pharmaceutical compostion for transdermic delivery |
| 05/21/2003 | CN1108783C Wound medicine moisture maintaining dressing |
| 05/20/2003 | US6566566 Dimerization of a C6-12 olefin mixture in which the hexene isomer fraction has less than 30% by weight of linear isomers in the presence of a nickel catalyst; derivatization to give primary alcohols, and optional subsequent alkoxylation |
| 05/20/2003 | US6566560 Resorcinolic compounds |
| 05/20/2003 | US6566554 Including amino benzothiophenones; useful for treatment of inflammatory diseases in which the production of cytokines is involved in the pathogenesis |
| 05/20/2003 | US6566543 2-arachidonylglycerol (2-AG)-an inhibitor of tumor necrosis factor-α and neuroprotector of brain in closed head injury |
| 05/20/2003 | US6566542 Such as 17-alpha-fluoro-11-beta-(4-(2-(1-piperidinyl) ethoxy) phenyl)-estra-1,3,5(10)-trien-3-ol for treatment of osteoporosis and cardiovascular protection; side effect reduction; provides alternative to estradiol |
| 05/20/2003 | US6566540 Anidepressant |
| 05/20/2003 | US6566538 Substituted oxygen alicyclic compounds, including methods for synthesis thereof |
| 05/20/2003 | US6566526 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 05/20/2003 | US6566517 Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy |
| 05/20/2003 | US6566514 Antisense oligonucleotides for use in the treatment of tumors |
| 05/20/2003 | US6566509 Compound for use as bactericide |
| 05/20/2003 | US6566506 Useful in extending the in vivo circulating life of biologically active materials |
| 05/20/2003 | US6566491 Cyclopeptide derivatives |
| 05/20/2003 | US6566407 Administering to a patient suffering from kidney stone calcium oxalate deposit) therapeutically effective amount of one or more crosslinked aliphatic amine polymers such as polyallylamine, polydiallylamine or polyvinylamine |
| 05/20/2003 | US6566405 Drugs, cosmetics or dietary supplements; immunomodulation, antiallergens (IgE mediated allergies, e.g., asthma, rhinitis, eczema); anaphylaxis; autoimmune disorders, e.g., Crohn's disease, antiarthritic and ulcer agents; analgesics |
| 05/20/2003 | US6566404 Treatment of drug-induced sleepiness |
| 05/20/2003 | US6566402 Trisodium citrate |
| 05/20/2003 | US6566401 Treating or preventing drug toxicity using a toxicity reducing amount of N-acetylcysteine |
| 05/20/2003 | US6566400 Administering cyclic amino acids, such as gabapentin and pregabalin compounds for therapy of physiological conditions associated with the use, or sequelae of use, of cocaine or other psychomotor stimulants and other addictive |
| 05/20/2003 | US6566399 Human oral mucosal and epidermal keratinocytes; antiinflammatory agents for trauma, exelcymosis, burns, antiulcer agents and angular cheilosis; cosmetics; wound-caused dermatitis and skin senescence |
| 05/20/2003 | US6566398 Method for treatment of external secretion disorders |
| 05/20/2003 | US6566397 As antitumor agents; acyclic isoprenoid such as farnesol, coupled by way of an ether linkage to a cyclic isoprenoid with a known tumor-suppressive activity such as hydroxyphenyl acetate |
| 05/20/2003 | US6566396 Carbetapentane tannate and chlorpheniramine tannate which are effective when administered orally for the symptomatic relief of coryza associated with the common cold, sinusitis, allergic rhinitis, and unproductive cough |
| 05/20/2003 | US6566395 Methods of treating proliferative disorders |
| 05/20/2003 | US6566392 For preparing aqueous bait for controlling flies |
| 05/20/2003 | US6566390 Inhibiting a PTPase treating type 1 and 2 diabetes, insulin resistance and pathological obesity |
| 05/20/2003 | US6566389 For prophylaxis and therapy of tardive dyskensia |
| 05/20/2003 | US6566387 For therapy of psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease, ulcerative colitis, stroke, septic shock |
| 05/20/2003 | US6566382 Stabilized isothiazolone-containing compositions |
| 05/20/2003 | US6566379 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 05/20/2003 | US6566377 Have utility as, inter alia, hypoglycemic, and anti-obesity agents. |
| 05/20/2003 | US6566376 Diphenyl-piperidine derivative |
| 05/20/2003 | US6566375 Elevation of HDL cholesterol by 4-[(aminothioxomethyl)-hydrazono]-N-(substituted)-4-arylbutanamides |
| 05/20/2003 | US6566374 Topically administering loperamide, or a pharmaceutically acceptable salt thereof, in a suitable carrier for therapy or prophylaxis of microbial infections associated with skin disorders |
| 05/20/2003 | US6566372 Useful in female hormone replacement therapy and as modulators of fertility; therapy of dysfunctional uterine bleeding, dysmenorrhea, endometriosis, leiomyomas (uterine fibroids), hot flashes, mood disorders, meningiomas, cancer |
| 05/20/2003 | US6566371 Intraperitoneal administration of adenosine for the treatment of prevention of gastrointestinal of systemic diseases |
| 05/20/2003 | US6566370 Administering decahydroisoquinoline-3-carboxylic acid derivative for therapy of migraine |
| 05/20/2003 | US6566369 Administering to a non-obstipative patient for the treatment and/or prophylaxis of irritable bowel syndrome, 5HT3-receptor antagonist, such as cilansetron or hydrochloride salt of cilansetron |
| 05/20/2003 | US6566368 Aministering apomorphine or a pharmaceutically acceptable acid addition salt thereof intranasally and in an amount sufficient to induce an erection adequate for vaginal penetration but less than the amount that induces substantial nausea |
| 05/20/2003 | US6566367 Spiro[isobenzofuran-1,4′-piperidin]-3-ones and 3H-spiroisobenzofuran-1,4′-piperidines |
| 05/20/2003 | US6566366 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 05/20/2003 | US6566365 Method for the treatment of Flaviviridea viral infection using nucleoside analogues |
| 05/20/2003 | US6566364 Linear or cyclic ureas |
| 05/20/2003 | US6566363 5-amino-3-substituted-pyrazolo(4,5-d)thiazole compounds that mediate and/or inhibit the activity of cyclin-dependent kinases, useful for treating cancer, angiogenesis and cellular proliferation |
| 05/20/2003 | US6566362 Use as topical antibiotics |
| 05/20/2003 | US6566361 Concurrent administration of acetaminophen with an azapirone such as buspirone. |
| 05/20/2003 | US6566360 2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors |
| 05/20/2003 | US6566359 For use as platelet- activating factor antagonists, inhibitors of certain protein kinases, transcriptional inhibitors of COX-2(cyclooxygenase-2) expression, and as agents in protecting brain tissue from injuries related to trauma |
| 05/20/2003 | US6566358 Cyclocarbamate derivatives as progesterone receptor modulators |
| 05/20/2003 | US6566357 Spirocyclic-6,7-dihydro-5H-pyrazolo[1,2-a]pyrazol-1-ones which control inflammatory cytokines |
| 05/20/2003 | US6566355 Useful in combination with beta -lactam antibiotics in the control of beta -lactamase forming pathogens |
| 05/20/2003 | US6566354 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
| 05/20/2003 | US6566353 Method of treating malignancy associated hypercalcemia using active vitamin D analogues |
| 05/20/2003 | US6566352 Administering alpha -hydroxy-2-methylene-19-nor-pregnacalciferol compound for therapy of psoriasis |
| 05/20/2003 | US6566351 Administering dihydroxyvitamin D3 derivative for inhibiting bone metastasis of malignant tumor in a patient in need of such inhibition and without treating the underlying cancer |
| 05/20/2003 | US6566350 Minocycline-containing compositions |
| 05/20/2003 | US6566347 For therapy of endometriosis, infertility, hereditary angioedema, autoimmune disease, premenopausal abnormal bleeding, migraine headaches, and metastatic and fibrocystic breast diseases |
| 05/20/2003 | US6566346 Oral skin improving agent, skin improving method, and food composition for improving skin |
| 05/20/2003 | US6566345 Polyacid/polyalkylene oxide foams and gels and methods for their delivery |
| 05/20/2003 | US6566344 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B |
| 05/20/2003 | US6566340 Aryl-substituted propanolamine derivatives, their preparation, pharmaceuticals comprising them, and their use |
| 05/20/2003 | US6566339 Administering analogue of mannose-6-phosphate for healing of wounds or fibrotic disorders |
| 05/20/2003 | US6566336 Compounds alkylating specific base sequence of DNA and method for synthesizing the same |
| 05/20/2003 | US6566328 Administering to the patient a therapeutically effective amount of a polypeptide for therapy of patient in need of agonist effect of human growth hormone |
| 05/20/2003 | US6566324 Preventing airway mucus production by administration of EGF-R antagonists |
| 05/20/2003 | US6566127 Enzymatic nucleic acid for use in the treatment of tumors, vision defects, arthritis and skin disorders |
| 05/20/2003 | US6566123 Biomass containing Thraustochytriales microflora |
| 05/20/2003 | US6566120 Contacting compactin with an agent derived from Actinomadura under conditions in which agent converts compactin to pravastatin; anticholesterol agent |
| 05/20/2003 | US6566106 Process for the isolation of clavulanic acid and of pharmaceutically acceptable salts thereof |
| 05/20/2003 | US6566093 Alphavirus cDNA vectors |
| 05/20/2003 | US6566084 Detecting hydrolysis of cocaine compound; obtain cocaine mixture, incubate with antibody, monitor generation of benzoic zacid |
| 05/20/2003 | US6566081 Detection of modulator of steroid hormone activity; obtain cells, incubate with enzyme inhibitors of varying concentrations, measure the effect of each concentration on phosphatidyl inositol-3-kinase activity in cells |
| 05/20/2003 | US6566080 Assay for and uses of peptide hormone receptor agonists |
| 05/20/2003 | US6566078 36P6D5: secreted tumor antigen |
| 05/20/2003 | US6566046 Platelet storage media mixture of sodium chloride, sodium citrate, sodium acetate, sodium phosphate ans psoralen |
| 05/20/2003 | US6565997 Superior in vibration transmittability between ceramic substrate and piezoelectric |
| 05/20/2003 | US6565896 Cholesterol treatment formulation |
| 05/20/2003 | US6565895 Side-effect reduction of anti-cancer therapy |
| 05/20/2003 | US6565894 Healthcare formulations comprising imidazole and hydrogen peroxide |
| 05/20/2003 | US6565890 Inorganic reaction product containing tungsten and vanadium oxide |
| 05/20/2003 | US6565883 Delay dissolving in water, gastric juice |
| 05/20/2003 | US6565882 Four dosage forms with different release profiles providing for initial release of a beta lactam antibiotic followed by release of a beta-lactamase inhibitor |
| 05/20/2003 | US6565880 Antiinflammatory agents |
| 05/20/2003 | US6565879 Neutralization; adjustment drug flux |
| 05/20/2003 | US6565876 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug |
| 05/20/2003 | US6565875 Microcapsules for administration of neuroactive agents |
| 05/20/2003 | US6565864 For conditioning skin, stability |
| 05/20/2003 | US6565859 Galenical formulations |
| 05/20/2003 | US6565857 Coding human leukocyte antigen; anticancer, antitumor agent |
| 05/20/2003 | US6565854 Killing microorganisms, especially human pathogens; use in would dressings; animal feeds; vaccines |